Dianthus Therapeutics, Inc. /DE/ Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $352K, a 49.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $352K -$346K -49.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $442K +$442K Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $530K +$530K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $615K -$199K -24.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $698K -$23.2M -97.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $0 -$24.7M -100% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $0 -$25.4M -100% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $814K +$814K Dec 31, 2022 10-K 2024-03-21
Q3 2022 $23.9M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $24.7M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $25.4M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 8-K 2023-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.